MARLENA AUSTIN: Open Payments
NPI 1770252561 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 17 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $484 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $264 |
| Novo Nordisk Inc | 2 | $48 |
| Lilly USA, LLC | 2 | $34 |
| Verona Pharma, Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: BREZTRI, Rybelsus, MOUNJARO, Ohtuvayre, AIRSUPRA, FARXIGA, M-M-R II, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
